United States · FDA National Drug Code directory

Vaccinosis Nosode 4004

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63083-4004_2edeb83d-2ef5-46ef-898e-93e1e0c40569
Product NDC: 63083-4004
Form: LIQUID
Composition / generic term: Vaccinosis Nosode
Labeler: Professional Complementary Health Formulas
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19840815
Source listing expiry: 20271231

Source-listed ingredients

OYSTER SHELL CALCIUM CARBONATE, CRUDE — 6 [hp_X]/59mL
SILICON DIOXIDE — 6 [hp_X]/59mL
THUJA OCCIDENTALIS LEAF — 6 [hp_X]/59mL
DIPHENYLTRICHLOROETHANE — 30 [hp_X]/59mL
LAURTRIMONIUM BROMIDE — 30 [hp_X]/59mL
MUMPS VIRUS — 30 [hp_X]/59mL
ANGUILLA ROSTRATA BLOOD SERUM — 30 [hp_X]/59mL
SERUM, HORSE — 30 [hp_X]/59mL
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) — 30 [hp_X]/59mL

These values do not establish equivalence or a dose recommendation.

Packages

59 mL in 1 BOTTLE, DROPPER (63083-4004-2) · 63083-4004-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →